Industry NewsNovel Drug for Mild-to-Moderate Alzheimer's Disease Demonstrates Safety and Tolerability at 18-Months
Editorial Article8 Radical Advances in the Evolutionary Battle between Science & Pathogens - Special Feature
Editorial ArticlePreventing DNA Contamination: Tackling the Phantom of Heilbronn Legacy with Eppendorf
Editorial ArticleContinuous Live Imaging Reveals Why Some Prostate Cancer Cells Resist Androgen-Deprivation Therapy
